Chiral separation of potent corticotropin-releasing factor-1 receptor antagonists by supercritical fluid chromatography.
Qian-Cutrone
Jingfang
J
Bristol-Myers Squibb Co., Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA. jingfang.cutrone@bms.com
Hartz
Richard
R
Ahuja
Vijay T
VT
Vrudhula
Vivekananda M
VM
Wu
Dauh-Rurng
DR
Dalterio
Richard A
RA
Wang-Iverson
David
D
Bronson
Joanne J
JJ
D000688:Amylose / Q000031:analogs & derivatives; D025924:Chromatography, Supercritical Fluid; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism; D006801:Humans; D048448:Phenylcarbamates; D011719:Pyrazines / Q000032:analysis / Q000302:isolation & purification*; D018019:Receptors, Corticotropin-Releasing Hormone / Q000037:antagonists & inhibitors* / Q000378:metabolism; D013237:Stereoisomerism; D000099052:CRF Receptor, Type 1
D048448:Phenylcarbamates; D011719:Pyrazines; D018019:Receptors, Corticotropin-Releasing Hormone; C080033:Chiralpak AD; D000099052:CRF Receptor, Type 1; D000688:Amylose; D003346:Corticotropin-Releasing Hormone